Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LLY | NVO | JNJ | ||
| Company | Eli Lilly and Company | Novo Nordisk A/S ADR | Johnson & Johnson | ||
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | ||
| Open | 902.71 | 141.69 | 146.43 | ||
| High | 912.00 | 143.37 | 147.15 | ||
| Low | 878.50 | 139.03 | 145.74 | ||
| Last | 906.71 | 142.98 | 146.03 | ||
| Change | -7.66 | -2.44 | -0.41 | ||
| % Change | -0.84% | -1.68% | -0.28% | ||
| Volume | 4,584,600 | 6,594,400 | 5,491,900 | ||
| 20-Day Average Volume | 2,754,565 | 3,744,960 | 6,791,370 | ||
| Previous Close | 914.37 | 145.42 | 146.44 | ||
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 879.47 | 142.62 | 146.66 | ||
| 20-Day Raw Stochastic | 89.80% | 58.21% | 36.82% | ||
| 20-Day Relative Strength | 70.72% | 57.71% | 44.80% | ||
| Weighted Alpha | +100.09 | +79.23 | -9.73 | ||
| Today's Opinion | 100% Buy | 100% Buy | 100% Sell | ||
| Previous Opinion | 100% Buy | 100% Buy | 100% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.23% since 06/25/24 | -2.68% since 06/25/24 | -0.79% since 06/25/24 | ||
| Low | 878.50 on 07/02/24 | 139.03 on 07/02/24 | 144.84 on 06/27/24 | ||
| High | 916.83 on 07/01/24 | 145.99 on 07/01/24 | 148.70 on 07/01/24 | ||
| 1-Month | |||||
| %Chg | +10.53% since 05/31/24 | +5.69% since 05/31/24 | -0.44% since 05/31/24 | ||
| Low | 817.62 on 06/05/24 | 133.68 on 06/03/24 | 143.88 on 06/13/24 | ||
| High | 916.83 on 07/01/24 | 148.15 on 06/25/24 | 149.72 on 06/24/24 | ||
| 3-Month | |||||
| %Chg | +18.69% since 04/02/24 | +13.06% since 04/02/24 | -7.42% since 04/02/24 | ||
| Low | 718.30 on 04/25/24 | 121.29 on 05/03/24 | 143.13 on 04/18/24 | ||
| High | 916.83 on 07/01/24 | 148.15 on 06/25/24 | 158.05 on 04/03/24 | ||
| 6-Month | |||||
| %Chg | +53.11% since 01/02/24 | +40.03% since 01/02/24 | -8.71% since 01/02/24 | ||
| Low | 598.80 on 01/03/24 | 102.03 on 01/03/24 | 143.13 on 04/18/24 | ||
| High | 916.83 on 07/01/24 | 148.15 on 06/25/24 | 163.58 on 01/22/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 869,021,824 | 652,576,896 | 352,434,080 | ||
| Shares Outstanding, K | 950,405 | 4,487,532 | 2,406,679 | ||
| Annual Sales | 34,124,100,000 | 33,724,300,000 | 85,159,000,000 | ||
| Annual Net Income | 5,240,400,000 | 12,150,770,000 | 35,153,000,000 | ||
| Last Quarter Sales | 8,768,000,000 | 9,514,810,000 | 21,383,000,000 | ||
| Last Quarter Net Income | 2,242,900,000 | 3,699,260,000 | 3,255,000,000 | ||
| 60-Month Beta | 0.41 | 0.41 | 0.52 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.58 on 04/30/24 | 0.83 on 05/02/24 | 2.71 on 04/16/24 | ||
| Latest Earnings Date | 08/13/24 | 08/08/24 | 07/17/24 | ||
| Most Recent Dividend | 1.300 on 05/15/24 | 0.663 on 03/22/24 | 1.240 on 05/20/24 | ||
| Next Ex-Dividends Date | 08/15/24 | 03/22/24 | 05/20/24 | ||
| Ratios | |||||
| Price/Earnings ttm | 124.37 | 49.22 | 13.97 | ||